Why the pandemic provides us with a preface to future research

View the accessible transcript of this podcast

Dr Hugh Davies talks to Professor Allan Gaw about how research ethics approval services adpated during the pandemic to rapidly approve urgent public health research applications.

As well as pointing to practical shifts, such as the switch from fewer face to face meetings to more frequent Zoom meetings, Dr Davies also describes a change of mindset. He describes how ethics panels had to revisit how they assess the benefit and risk balance when considering the burden of delivering research in a pandemic situation, against the desperate need to generate clinical evidence for what treatments work, and don't work.


This podcast is part of our 'Persectives from the Pandemic' series looking at the delivery of Complex and Innovative Design (CID) trials in the COVID-19 pandemic. You can access the full series of #ComplexInnovativeDesign trial podcasts on our website: www.nihr.ac.uk/documents/delivering-complex-and-innovative-trials-podcast-collection/29517

To find out more about how the NIHR supports complex and innovative design trials, visit:www.nihr.ac.uk/innovative-trials